BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2949541)

  • 21. Comparison of immunological and enzymatic properties of human urinary and pancreatic kallikrein.
    Fink E; Amouric M; Geiger R; Figarella C
    Hoppe Seylers Z Physiol Chem; 1982 Aug; 363(8):819-23. PubMed ID: 6922082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative specificity of porcine pancreatic kallikrein and bovine pancreatic trypsin. Importance of interactions N-terminal to the scissible bond.
    Bizzozero SA; Dutler H
    Arch Biochem Biophys; 1987 Aug; 256(2):662-76. PubMed ID: 3650053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human tissue kallikrein. I. Isolation and characterization of human pancreatic kallikrein from duodenal juice.
    Hofmann W; Geiger R
    Hoppe Seylers Z Physiol Chem; 1983 Apr; 364(4):413-23. PubMed ID: 6553015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New dipeptide fluorogenic substrates of human tissue kallikrein].
    Pozdnev VF; Rabinovich SE; Paskhina TS
    Bioorg Khim; 1991 Oct; 17(10):1352-6. PubMed ID: 1804119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The esterolytic specificity of bovine thrombin and Factor Xa.
    Lonsdale-Eccles JD; Hogg DH; Elmore DT
    Biochim Biophys Acta; 1980 Apr; 612(2):395-400. PubMed ID: 7370278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simple radioassay for human urinary kallikrein.
    Chung A; Ryan JW; Pena G; Oza NB
    Adv Exp Med Biol; 1979; 120A():115-25. PubMed ID: 495305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteolytic activation of tissue plasminogen activator by plasma and tissue enzymes.
    Ichinose A; Kisiel W; Fujikawa K
    FEBS Lett; 1984 Oct; 175(2):412-8. PubMed ID: 6566616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification and characterization of a kallikrein from human submaxillary glands.
    Fujimoto Y; Suzuki C; Watanabe Y; Matsuda Y; Akihama S
    Biochem Med Metab Biol; 1990 Dec; 44(3):218-27. PubMed ID: 2288765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens.
    Maier M; Austen KF; Spragg J
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):3928-32. PubMed ID: 6575386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein.
    El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F
    Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serine protease specificity for peptide chromogenic substrates.
    Mattler LE; Bang NU
    Thromb Haemost; 1977 Dec; 38(4):776-92. PubMed ID: 146272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specificity of human tissue kallikrein towards substrates containing Phe-Phe pair of amino acids.
    Pimenta DC; Chao J; Chao L; Juliano MA; Juliano L
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):473-9. PubMed ID: 10191281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzymology of porcine tissue kallikrein.
    Fiedler F
    Adv Exp Med Biol; 1983; 156():263-74. PubMed ID: 6552841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic characterization of rat tissue kallikrein using N alpha-substituted arginine 4-nitroanilides and N alpha-benzoyl-L-arginine ethyl ester as substrates.
    Sousa MO; Rodrigues CV; Pena HB; Alvarenga MG; Machado-Coelho GL; Santoro MM; Juliano MA; Juliano L; Figueiredo AF
    Braz J Med Biol Res; 1996 Mar; 29(3):327-34. PubMed ID: 8736125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of secondary interactions on the kinetics of peptide and peptide ester hydrolysis by tissue kallikrein and trypsin.
    Fiedler F
    Eur J Biochem; 1987 Mar; 163(2):303-12. PubMed ID: 3643848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new fluorogenic substrate method for the estimation of kallikrein in urine.
    Kato H; Adachi N; Iwanaga S; Abe K; Takada K; Kimura T; Sakakibara S
    J Biochem; 1980 Apr; 87(4):1127-32. PubMed ID: 6901529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological assay for tissue kallikrein: comparison with the synthetic substrate S2266.
    Campbell SK; Marshall KG; Millar JG; Raman GV; Albano JD
    Agents Actions Suppl; 1992; 38 ( Pt 1)():159-65. PubMed ID: 1466267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substrate specificities of tissue kallikrein and T-kininogenase: their possible role in kininogen processing.
    Chagas JR; Hirata IY; Juliano MA; Xiong W; Wang C; Chao J; Juliano L; Prado ES
    Biochemistry; 1992 Jun; 31(21):4969-74. PubMed ID: 1599922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide esters and nitroanilides as substrates for the assay of human urinary kallikrein.
    Fiedler F; Geiger R; Hirschauer C; Leysath G
    Hoppe Seylers Z Physiol Chem; 1978 Dec; 359(12):1667-73. PubMed ID: 738700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurements of enzymatic activities in pleural exudates with chromogenic substrates.
    Widström O; Chmielewska J; Blombäck M
    Thromb Res; 1986 Jun; 42(6):859-64. PubMed ID: 2941892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.